Techstars highlights Exactrx AI
Techstars profiled Exactrx, an AI startup aiming to automate claims and denials workflows with agentic approaches that the company says could cut into the roughly $166B in administrative losses. The profile frames agentic AI as a way to orchestrate denial remediation and workflow automation across payer-provider gaps. (x.com)
Techstars has put a spotlight on Exactrx, a Tennessee healthcare startup pitching artificial intelligence software to catch claim errors before insurers deny payment. (techstars.com) Techstars published the profile on March 25, 2026 and identified Exactrx as a “Techstars 2025” company led by chief executive and co-founder Athena Doshi. The firm says its software reduces denials and delays to care with “autonomous, embedded checklists.” (techstars.com) In plain terms, a healthcare claim is a provider’s bill to an insurer, and a denial is the insurer refusing to pay it. Exactrx says its system scans charts, checks billing and diagnosis codes, applies payer-specific rules, and builds a submission-ready packet before the claim goes out. (exactrx.ai) The company’s pitch is that hospitals and outpatient clinics lose money long before an appeal starts, because staff spend hours chasing missing documents, matching notes to insurer rules, and correcting incomplete files. Exactrx’s Wefunder page says those administrative failures add up to more than $166 billion a year and derail more than 30% of cases because documentation is missing or incomplete. (wefunder.com) That problem has grown as denials have risen. Healthcare Financial Management Association reported in February 2026 that initial denial rates tied to prior authorization and precertification reached 1.56% in 2025 through November, up from 1.46% in 2024, citing Kodiak Solutions data. (hfma.org) The “agentic” label refers to software that does more than draft text or summarize records. In denial management, vendors use the term for systems that monitor claims, identify likely failure points, route tasks, and prepare follow-up steps across medical record and billing systems. (hfma.org; aapc.com) Exactrx describes its version as “humans-in-the-loop,” meaning staff still review or complete work around the software rather than handing the process over entirely. Its website says the platform uses a “hub-and-spoke” approach to collect missing information and stop downgrades and denials before submission. (exactrx.ai) Techstars’ profile lands as startups and larger automation vendors are all chasing the same revenue-cycle budget inside healthcare. Products across the market now promise faster appeals, fewer manual follow-ups, and payer-specific workflows as providers try to cut administrative labor without adding headcount. (hfma.org; automationanywhere.com) Exactrx is still at the profile stage, not the public-company stage, so the clearest public facts are its product claims, its Techstars backing, and the size of the billing problem it is targeting. The bet is simple: if software can assemble a cleaner claim on the first pass, providers get paid faster and spend less time fighting denials. (techstars.com; exactrx.ai)
